STOCK TITAN
  1. Home
  2. Sec-filings
  3. BAK
  4. [6-K] BRASKEM SA Current Report (Foreign Issuer)

Braskem board holds August 24 extraordinary meeting

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

BRASKEM S.A. (BAK) reports that its Board of Directors held an extraordinary, non-presential meeting on August 24, 2026, with all board members participating. The meeting was chaired by Magda Maria de Regina Chambriard, with Lilian Bruno acting as secretary, and the minutes were approved and signed by all attending directors.

The company reiterates standard cautionary language regarding forward-looking statements, noting that its expectations depend on economic conditions, industry factors and operating assumptions, and may be affected by events such as the geological event in Alagoas, related legal proceedings, and COVID-19. The report is signed by Chief Financial Officer Carlos Augusto Machado Pereira de Almeida Brandão.

Positive

  • None.

Negative

  • None.
Board meeting date August 24, 2026 Date of the extraordinary non-presential Board of Directors meeting
CNPJ 42.150.391/0001-70 National Register of Legal Entities identification for BRASKEM S.A.
NIRE 29.300.006.939 State Registration number for BRASKEM S.A.
forward-looking statements regulatory
"This report on Form 6-K may contain forward-looking statements within the meaning"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
Private Securities Litigation Reform Act of 1995 regulatory
"forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995"
Form 20-F regulatory
"Please refer to our annual report on Form 20-F for the year ended December 31, 2019"
Form 20-F is the standardized annual disclosure that non-U.S. companies must file with the U.S. securities regulator when their shares are traded in the U.S.; it contains audited financial statements, a plain-language description of the business, management discussion, governance details and key risk factors. It matters to investors because it provides a consistent, comparable company “report card” and rulebook, helping buyers assess financial health, governance and risks before investing.

FAQ

What did BRASKEM S.A. (BAK) disclose about its Board of Directors meeting?
BRASKEM S.A. disclosed that its Board of Directors held an extraordinary, non-presential meeting on August 24, 2026, with all board members participating. The minutes were approved and signed by all attendees, including the chairperson and the secretary.

Who chaired the August 24, 2026 Board meeting of BRASKEM S.A. (BAK)?
The August 24, 2026 Board meeting of BRASKEM S.A. was chaired by Magda Maria de Regina Chambriard, who served as Chairperson of the Board during the session.

Who served as secretary at BRASKEM S.A.’s August 24, 2026 Board meeting?
Lilian Bruno served as secretary at the August 24, 2026 Board of Directors meeting of BRASKEM S.A., assisting the chairperson and recording the minutes.

Who signed the Form 6-K on behalf of BRASKEM S.A. (BAK)?
The report was signed on behalf of BRASKEM S.A. by Carlos Augusto Machado Pereira de Almeida Brandão, who is identified as the company’s Chief Financial Officer.

What does BRASKEM S.A. say about forward-looking statements in this 6-K?
BRASKEM S.A. states that forward-looking statements reflect management’s current views and are subject to risks and uncertainties, including economic conditions, industry factors, the geological event in Alagoas with related legal proceedings, and COVID-19, which could cause actual results to differ materially.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16
OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934


For the month of August, 2026

(Commission File No. 1-14862 )

 

 

BRASKEM S.A.

(Exact Name as Specified in its Charter)

 

N/A

(Translation of registrant's name into English)

 

 

Rua Eteno, 1561, Polo Petroquimico de Camacari
Camacari, Bahia - CEP 42810-000 Brazil

(Address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ___X___       Form 40-F ______

 

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1). _____

 

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7). _____

 

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ______       No ___X___

If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _____.

 

 
 

 

BRASKEM S.A.

National Register of Legal Entities (CNPJ) No. 42.150.391/0001-70

State Registration (NIRE) 29.300.006.939

Publicly Held Company

 

MINUTES OF THE BOARD OF DIRECTORS’MEETING

HELD ON AUGUST 24, 2026

 

1. DATE, TIME, AND PLACE: on August 24, 2026, held in a non-presential manner.

 

2. CALL NOTICE, ATTENDANCE AND PRESIDING BOARD: Extraordinary Meeting of the Board of Directors (“BoD”) of Braskem S.A. (“Braskem” or “Company”), with the participation of all Board members as indicated below. The Chairperson of the Board presided over the meeting, and Ms. Lilian Bruno acted as secretary

 

3. AGENDA, RESOLUTIONS AND SUBJECTS FOR ACKNOWLEDGEMENT OR OF INTEREST TO THE COMPANY:

 

3.1. Resolutions: After due analysis of the subject submitted for resolution, which the related materials were previously forwarded to the Board Members and shall remain duly filed at the Company’s Governance Portal, the following resolutions were unanimously adopted:

 

a)PD.CA/BAK-30/2026 - Request for Protective Measures by Braskem S.A. and Certain Subsidiaries: following prior review and a favorable recommendation by the Executive Board and the Finance and Investment Committee, the Board Members approved PD.CA/BAK-30/2026 in order to: (i) approve, without restriction, the filing by the Company and certain subsidiaries, namely Braskem Netherlands B.V., Braskem Netherlands Inc. B.V., Braskem Trading & Shipping B.V., Braskem Netherlands Finance B.V., and Braskem America Finance Company (together with the Company, the “Debtors”), of an Out-of-Court Restructuring Proceeding (Recuperação Extrajudicial) and the submission of the related restructuring plan, substantially in the form and on the terms and conditions described in Annex III to PD.CA/BAK-30/2026; (ii) approve the filing of applications for recognition abroad of the protective proceeding commenced in Brazil, including through the commencement of a Chapter 15 proceeding in the United States with respect to the Debtors, as applicable; (iii) approve the filing of any protective measures deemed necessary for the protection of the Debtors in other jurisdictions, as applicable; (iv) authorize the Company's Officers to instruct its representatives and the representatives of its subsidiaries, as necessary, at shareholders' meetings and before corporate governing bodies, to exercise their voting rights and take all appropriate and necessary actions to obtain and implement the approvals referred to in items (i), (ii), and (iii) above; and (v) authorize the Company's Management, acting directly or through duly appointed attorneys-in-fact, to perform all acts, take any and all measures, and execute all documents necessary for the implementation, formalization, and consummation of the approved resolutions, granting them sufficient authority to implement all measures required in connection therewith.
 
 

 

BRASKEM S.A.

National Register of Legal Entities (CNPJ) No. 42.150.391/0001-70

State Registration (NIRE) 29.300.006.939

Publicly Held Company

 

MINUTES OF THE BOARD OF DIRECTORS’MEETING

HELD ON AUGUST 24, 2026

 

3.2. SUBJECTS FOR ACKNOWLEDGEMENT/OF INTEREST TO THE COMPANY: nothing to record.

 

4. ADJOURNMENT: As there were no further matters to be discussed, the meeting was closed and these minutes were drawn up, and, after being read, discussed and found to be in order, were signed by all Board Members in attendance at the meeting, by the Chairperson and by the Secretary of the Meeting.

 

São Paulo/SP, August 24, 2026.

 

 

Magda Maria de Regina Chambriard   Lilian Bruno
Chairperson   Secretary
     
     
     
Hélio Baptista Novaes   Fernando Sabbi Melgarejo
 
 

 

BRASKEM S.A.

National Register of Legal Entities (CNPJ) No. 42.150.391/0001-70

State Registration (NIRE) 29.300.006.939

Publicly Held Company

 

MINUTES OF THE BOARD OF DIRECTORS’MEETING

HELD ON AUGUST 24, 2026

 

 

Isabella Saboya de Albuquerque   Luciano Galvão Coutinho
     
     
     
Marcelo Weick Pogliese   María Letícia De Freitas Costa
     
     
     
Octavio Cortes Pereira Lopes    Paulo Roberto Britto Guimarães
     
     
     
Walter Susini    William França da Silva

 

 

 

 

 
 

SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: August 24, 2026

  BRASKEM S.A.
       
       
  By:      /s/     Carlos Augusto Machado Pereira de Almeida Brandão
     
    Name: Carlos Augusto Machado Pereira de Almeida Brandão
    Title: Chief Financial Officer

 

DISCLAIMER ON FORWARD-LOOKING STATEMENTS

 

This report on Form 6-K may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are statements that are not historical facts, and are based on our management’s current view and estimates of future economic and other circumstances, industry conditions, company performance and financial results, including any potential or projected impact of the geological event in Alagoas and related legal proceedings and of COVID-19 on our business, financial condition and operating results. The words “anticipates,” “believes,” “estimates,” “expects,” “plans” and similar expressions, as they relate to the company, are intended to identify forward-looking statements. Statements regarding the potential outcome of legal and administrative proceedings, the implementation of principal operating and financing strategies and capital expenditure plans, the direction of future operations and the factors or trends affecting our financial condition, liquidity or results of operations are examples of forward-looking statements. Such statements reflect the current views of our management and are subject to a number of risks and uncertainties, many of which are outside of the our control. There is no guarantee that the expected events, trends or results will actually occur. The statements are based on many assumptions and factors, including general economic and market conditions, industry conditions, and operating factors. Any changes in such assumptions or factors, including the projected impact of the geological event in Alagoas and related legal proceedings and the unprecedented impact of COVID-19 pandemic on our business, employees, service providers, stockholders, investors and other stakeholders, could cause actual results to differ materially from current expectations. Please refer to our annual report on Form 20-F for the year ended December 31, 2019 filed with the SEC, as well as any subsequent filings made by us pursuant to the Exchange Act, each of which is available on the SEC’s website (www.sec.gov), for a full discussion of the risks and other factors that may impact any forward-looking statements in this presentation.

 

 

 

Source: View Original Filing on SEC EDGAR